Results 91 to 100 of about 11,121 (203)

Deep Learning Predicts Hematopoietic Stem Cell Aging From 3D Chromatin Images

open access: yesAging Cell, Volume 25, Issue 10, October 2026.
Deep learning identifies age‐associated chromatin architecture signatures in 3D images of hematopoietic stem cell nuclei, providing an interpretable imaging biomarker that distinguishes young from aged cells and detects chromatin rejuvenation after treatment.
Pablo Iáñez Picazo   +5 more
wiley   +1 more source

G9a/GLP methyltransferases inhibit autophagy by methylation-mediated ATG12 protein degradation

open access: yes, 2019
Previous studies showed that a lysine methyltransferase G9a inhibits autophagy by repressing transcription of autophagy genes. Here, we demonstrate a novel mechanism whereby G9a/GLP inhibit autophagy through post-translational modification of ATG12, a ...
Changhoon Kim (35659)
core   +3 more sources

Dual epigenetic modifiers for cancer therapy

open access: yesMolecular & Cellular Oncology, 2017
Epigenetic drug discovery is an emerging strategy for the treatment of cancer and other pathologies. Here, we discuss our recent discovery of first-in-class dual reversible inhibitors of the histone methyltransferase activity of G9a/EHMT2 and DNA ...
Edurne San José-Enériz   +4 more
doaj   +1 more source

Cinnamaldehyde From Cinnamon as a Food‐Derived Bioactive: Phytochemistry, Anticancer Mechanisms, Bioavailability, Nanoformulation and Safety

open access: yesFood Frontiers, Volume 7, Issue 5, September 2026.
Cinnamaldehyde derived from Cinnamomum species exerts multitarget anticancer effects by promoting oxidative stress, mitochondrial dysfunction, apoptosis, cell‐cycle arrest, autophagy, and epigenetic changes, and by suppressing mitogen‐activated protein kinase (MAPK), phosphoinositide 3‐kinase/protein kinase B/mechanistic target of rapamycin (PI3K/Akt ...
Gervason Moriasi   +6 more
wiley   +1 more source

IKK Regulates Histone Methyltransferase G9a to Promote Cancer Progression

open access: yes, 2014
G9a 是哺乳動物的組蛋白甲基轉移酶,在不同癌症中常常會高度表現,使得抑癌基因靜默而無法轉錄,調控腫瘤發展的進程。由於轉譯後修飾對於調控蛋白的功能十分重要,而目前沒有文獻探討G9a的轉譯後修飾,因此我們利用生物資訊的軟體預測G9a可能的磷酸化位置,在其中發現可能具有IKKa/b的磷酸化位置。 在本篇的研究中,我們在293T細胞和乳癌細胞MCF-7、BT549中利用免疫沉澱方法以及GST pull down assay 證明了G9a可以在in vivo及 in vitro的情況下跟IKKa/b結合,在in
Lei, Kai-Hang, 李啟恆
core  

Oxysterols in Cancer: From Biosynthesis and Pathophysiology to Targeted Therapeutics

open access: yesMedComm – Oncology, Volume 5, Issue 3, September 2026.
Mechanisms by which oxysterol targeting may enhance immunotherapy efficacy. This figure illustrates potential metabolic interventions that may improve antitumor immunity by modulating oxysterol related pathways. CH25H modulation may reduce 25‐HC accumulation, promote the conversion of cold tumors into hot tumors, and increase T cell infiltration and PD‐
Haili Shang, Yongsheng Li
wiley   +1 more source

H3K9 Histone Methyltransferase G9a Promotes Cancer Cell Invasion and Metastasis

open access: yes, 2013
G9a 是一種哺乳動物的組蛋白甲基轉移酶,有助於抑癌基因的非遺傳層次基因靜默。新的證據顯示,G9a 是維持腫瘤惡性型態所必須的,但G9a 對腫瘤轉移功能的調控並未被探討。本研究證實,在高度侵襲能力的肺癌細胞,G9a 的表現有增高的趨勢,並且高表現的G9a 和病人預後差呈現相關性。在高G9a 表現的肺癌細胞株,利用RNA 干擾技術抑制內生性的G9a 表現,在細胞實驗和動物實驗中均觀察到癌細胞移動和侵襲轉移能力受到抑制。另一方面,在G9a 表現低的肺癌細胞株,外送G9a 表現載體使肺癌細胞的G9a 過度表現,
Chen, Min-Wei, 陳民瑋
core  

Twisting the End Game: How Telomere Chromatin Modifications Shape Telomere Maintenance

open access: yesAging Cell, Volume 25, Issue 9, September 2026.
Chromatin modifications on telomeres are linked to the mode of telomere DNA replication. A coupled feedforward loop model is proposed based on these to lock the ALT cancer cells in this alternative mode of telomere replication. ABSTRACT Cell division inevitably shortens telomeric DNA owing to the end‐replication problem.
Jie Wang   +8 more
wiley   +1 more source

G9a regulates temporal preimplantation developmental program and lineage segregation in blastocyst

open access: yeseLife, 2018
Early mouse development is regulated and accompanied by dynamic changes in chromatin modifications, including G9a-mediated histone H3 lysine 9 dimethylation (H3K9me2).
Jan J Zylicz   +6 more
doaj   +1 more source

Bone marrow cells can be converted into cardiac competent progenitors via inhibition of G9a Histone Methyltransferase G9a

open access: yesThe FASEB Journal, 2013
Given that the optimal treatment for the damaged heart is to replace dysfunctional myocytes, great effort has been made to develop stem cell therapies for regenerating cardiomyocytes (CM). We demonstrated previously that bone marrow (BM) have a capacity, albeit limited, to convert into CM.
Jinpu Yang   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy